CAS 863405-60-1

JW74

Description:

JW74, with the CAS number 863405-60-1, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its role as a selective inhibitor of certain protein kinases. It is primarily recognized for its potential applications in cancer research, as it targets specific pathways involved in tumor growth and proliferation. JW74 exhibits a unique molecular structure that contributes to its selectivity and potency against its target kinases. The compound is typically characterized by its solubility in organic solvents and its stability under standard laboratory conditions. In terms of biological activity, JW74 has been studied for its effects on cell signaling pathways, making it a valuable tool for understanding the mechanisms of cancer progression and for the development of targeted therapies. As with many experimental compounds, further research is necessary to fully elucidate its pharmacokinetics, toxicity, and therapeutic potential in clinical settings.

JW74

CAS: 863405-60-1

JW74 antagonizes LiCl-induced activation of the canonical Wnt signaling (IC50: 420 nM).

Formula: C₂₄H₂₀N₆O₂S

Purity: 95.00%

Color and Shape: Solid

Molecular weight: 456.52

Ref: TM-T15633

JW74

CAS: 863405-60-1

JW74

Purity: ≥95%

Molecular weight: 456.52g/mol

Ref: 54-BUP10359

JW74

CAS: 863405-60-1

Formula: C₂₄H₂₀N₆O₂S

Molecular weight: 456.52

Ref: 7W-GL9741

JW 74

CAS: 863405-60-1

JW 74 is a small molecule drug that binds to the epidermal growth factor receptor (EGFR) and inhibits its ability to activate. EGFR is a protein tyrosine kinase that is activated in many cancers, including cervical cancer. JW 74 has been shown to inhibit the proliferation of cells in culture, as well as autophagy and cancer cell growth in vivo. This drug has also been shown to have anti-inflammatory properties, which may be due to its ability to inhibit the activation of β-catenin.

Formula: C₂₄H₂₀N₆O₂S

Purity: Min. 95%

Molecular weight: 456.52 g/mol

Ref: 3D-NJB40560